Passer à la navigation principale Passer à la recherche Passer au contenu principal

National protocol for diagnosis and care of congenital aniridia: Summary for the attending physician

Titre traduit de la contribution: Protocole national de diagnostic et de soins (PNDS) de l'aniridie congénitale: synthèse pour le médecin traitant
  • Groupe Rédacteur Relecteur PNDS Aniridie
  • Hôpital Necker-Enfants Malades
  • Laboratoire de Probabilités et Modèles Aléatoires
  • CHNO des XV-XX
  • France; Université Clermont Auvergne
  • Pôle Gérontologie
  • CHU Toulouse
  • Laboratoire de Biochimie
  • University Hospital of Montpellier
  • AP–HP
  • Association basse vision ARIBa
  • Cabinet Ophtalmologie Foch
  • INSERM U1163
  • CHRU Strasbourg
  • CNRS
  • Paris 17ème
  • Ophtalmologie
  • Service d'Hématologie Biologique
  • CHU de Marseille
  • Hôpital de la Croix Rousse
  • Orthoptiste
  • Administratrice de l'Association GÊNIRIS
  • Hôpital Fondation Adolphe de Rothschild
  • Cabinet Centre Vision Sud
  • Association GÊNIRIS
  • Centre Hospitalier Universitaire
  • Sorbonne Université
  • Assistance Publique-Hôpitaux de Paris
  • AP-HP
  • Assistance Publique Hôpitaux de Paris

Résultats de recherche: Contribution à un journalArticle de révisionRevue par des pairs

3 Citations (Scopus)

Résumé

Congenital aniridia is a rare panocular disease defined by a national diagnostic and care protocol (PNDS) validated by the HAS. In most cases, it is due to an abnormality in the PAX6 gene, located at 11p13. Aniridia is a potentially blinding autosomal dominant disease with high penetrance. The prevalence varies from 1/40,000 births to 1/96,000 births. Approximately one third of cases are sporadic. Ocular involvement includes complete or partial absence of iris tissue, corneal opacification with neovascularization, glaucoma, cataract, foveal hypoplasia, optic disc hypoplasia and ptosis. These ocular disorders coexist to varying degrees and progress with age. Congenital aniridia manifests in the first months of life as nystagmus, visual impairment and photophobia. A syndromic form such as WAGR syndrome, WAGRO syndrome (due to the risk of renal Wilms tumor) or Gillespie syndrome (cerebellar ataxia) must be ruled out. Systemic associations may include diabetes, due to expression of the PAX6 gene in the pancreas, as well as other extraocular manifestations. Initial assessment is best carried out in a referral center specialized in rare ophthalmologic diseases, with annual follow-up. The management of progressive ocular involvement must be both proactive and responsive, with medical and surgical management. Visual impairment and photophobia result in disability, leading to difficulties in mobility, movement, communication, learning, fine motor skills, and autonomy, with consequences in personal, school, professional, socio-cultural and athletic life. Medico-socio-educational care involves a multidisciplinary team. Disability rehabilitation must be implemented to prevent and limit situations of handicap in activities of daily living, relying on the Commission for the Rights and Autonomy of People with Disabilities (CDAPH) within the Departmental House of People with Disabilities (MDPH). The general practitioner coordinates multidisciplinary medical and paramedical care.

Titre traduit de la contributionProtocole national de diagnostic et de soins (PNDS) de l'aniridie congénitale: synthèse pour le médecin traitant
langue originaleAnglais
Pages (de - à)647-652
Nombre de pages6
journalJournal Francais d'Ophtalmologie
Volume45
Numéro de publication6
Les DOIs
étatPublié - 1 juin 2022
Modification externeOui

SDG des Nations Unies

Ce résultat contribue à ou aux Objectifs de développement durable suivants

  1. SDG 3 - Bonne santé et bien-être
    SDG 3 Bonne santé et bien-être

Empreinte digitale

Examiner les sujets de recherche de « Protocole national de diagnostic et de soins (PNDS) de l'aniridie congénitale: synthèse pour le médecin traitant ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation